Introduction Relapsing multiple sclerosis (RMS) is characterized by episodes of acute demyelination and chronic neuroinflammation mediated by T cells, B cells, and microglia (1). Despite advances in disease-modifying therapies (DMTs), many patients continue to experience breakthrough disease activity or intolerance to lymphocyte-depleting treatment
Young Girl Presented with Irritability and Abnormal Behavior
2254 Reached10 Comments4 Likes
Management of Infantile Myoclonic Seizures
1169 Reached3 Comments3 Likes
Unconscious Male in ED following Loss of Motorcycle Control
828 Reached2 Comments2 Likes
Headache with Clinically Non-functioning Pituitary Adenoma
818 Reached1 Comments4 Likes
OSA in Child
597 Reached3 Comments2 Likes